China invested $18 million in HIV vaccine research in 2010, becoming the third largest contributor globally, after the US and the European Union, UNAIDS has said.
Globally, HIV vaccine research and development funding stood at $859 million in 2010, around $9 million less than in 2009, while China increased its spending by $4 million over the same period, the China Daily said citing a report issued jointly by international organisations working for AIDS.
“The long-term nature of vaccine research will require sustained investments globally and more developing countries like China are expected to shoulder more responsibilities,” an official said.
The report, however, said that overall global funding for HIV research has “flattened out” since 2000 and some early supporters, such as Canada and Sweden, have cut back. In the EU, funding has declined by 23 percent since 2007.
Shao Yiming, a top official at China’s National Centre for AIDS/STD Control and Prevention, said that in contrast, the Chinese government has pledged to further boost funding for HIV vaccine development by at least 20 percent in the five years.